Structure-activity relationship for antiarrhytmic actions of  -receptor blocking drugs.
D000433:1-Propanol / Q000037:antagonists & inhibitors; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000037:antagonists & inhibitors*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000037:antagonists & inhibitors*; D002302:Cardiac Output / Q000187:drug effects; D003315:Cornea / Q000187:drug effects; D003408:Cresols / Q000037:antagonists & inhibitors; D004071:Digitalis Glycosides / Q000037:antagonists & inhibitors; D004285:Dogs; D004347:Drug Interactions; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006168:Guinea Pigs; D006221:Halothane; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D008168:Lung / Q000187:drug effects; D008297:Male; D010042:Ouabain / Q000037:antagonists & inhibitors; D011437:Propylamines / Q000037:antagonists & inhibitors; D012867:Skin / Q000187:drug effects; D013329:Structure-Activity Relationship
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D003408:Cresols; D004071:Digitalis Glycosides; D011437:Propylamines; D010042:Ouabain; D000433:1-Propanol; D006221:Halothane; D004837:Epinephrine